Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Qanatpharma Ag

Clinical trials sponsored by Qanatpharma Ag, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could a cystic fibrosis drug boost brain blood flow in heart failure? Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Could a cystic fibrosis drug boost brain blood flow in heart failure?

Disease control Recruiting now

This study tests whether lumacaftor, a drug used for cystic fibrosis, can improve blood flow to the brain and thinking abilities in people with stable heart failure and reduced pumping function. About 60 participants will receive either lumacaftor or a placebo for one month. The …

Phase 2 • Sponsor: Qanatpharma AG • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC